LIQUARD THOMAS enters PHARMACYTE BIOTECH, INC. with 1.67K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.67K | Direct |
| Total | 1.67K | 1.67K direct |
Stock Option (right to buy)
DirectUnderlying shares
334.00
Shares owned
N/A
Exercise price
26.55
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
334.00
Shares owned
N/A
Exercise price
36.00
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
167.00
Shares owned
N/A
Exercise price
156.00
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
167.00
Shares owned
N/A
Exercise price
87.00
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
334.00
Shares owned
N/A
Exercise price
80.85
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
334.00
Shares owned
N/A
Exercise price
60.60
Expiration
—
Exercise window
—
Underlying
1.67K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 26.55 | — | — | 334.00 | N/A |
| Stock Option (right to buy) Direct | Common Stock | 36.00 | — | — | 334.00 | N/A |
| Stock Option (right to buy) Direct | Common Stock | 156.00 | — | — | 167.00 | N/A |
| Stock Option (right to buy) Direct | Common Stock | 87.00 | — | — | 167.00 | N/A |
| Stock Option (right to buy) Direct | Common Stock | 80.85 | — | — | 334.00 | N/A |
| Stock Option (right to buy) Direct | Common Stock | 60.60 | — | — | 334.00 | N/A |
| Total | 1.67K | 0.00 | ||||